1 / 6

Leading Players in Anti-Obesity Drugs Market

<br>Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Anti-Obesity Drugs Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. <br><br>Read Full Report: http://www.transparencymarketresearch.com/anti-obesity-drugs-market.html

Download Presentation

Leading Players in Anti-Obesity Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Transparency Market Research Single User License: USD 4315.5   Flat 10% Discount!!   Free Customization as per your requirement   You will get Custom Report at Syndicated Report price   Report will be delivered with in 15-20 working days Anti-Obesity Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.co m Request Sample Buy Now

  2. REPORT DESCRIPTION Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Anti-Obesity Drugs Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. GlobalAnti-Obesity Drugs Market: Overview The World Health Organization reveals that global obesity has more than doubled since 1980, with over 1.9 billion adults overweight in 2014, of which, more than 600 million were obese. Percentage-wise, an estimated 39% of adults were overweight and 13% were obese in 2014. An additional 42 million children below the age of five were found to be overweight or obese in 2013. Based on two surveys conducted by the Centers for Disease Control and Prevention, an astounding 68.8% of the U.S. adult population is considered to be overweight or obese. It is no surprise, then, that today, most of the world’s population lives in countries where obesity and overweight are claiming more lives than underweight and malnutrition. Browse Full Report with TOC: http://www.transparencymarketresearch.com/anti-obesity-drugs-market.html This alarming rise in the prevalence of obesity, particularly in the developed region of North America, has been single-handedly propelling the anti-obesity drugs market. Anti-obesity drugs – both prescription and OTC – are of two main types: Centrally- acting drugs and peripherally-acting drugs. These contain a host of pharmacological agents that control or reduce weight by altering either the absorption of calories or regulating appetite. This comprehensive research publication offers clients an exhaustive database of accurate, authentic, objective, and the most recent information on the global anti-obesity drugs market. The overall market is segmented based on several key criteria and each segment is thoroughly evaluated to identify the leading and weakest categories. Statistical data and inputs from industry experts support the qualitative data offered in the report and help clients devise actionable and profitable decisions for the future. Global Anti-Obesity Drugs Market: Key Trends and Regional Outlook

  3. The global market for anti-obesity drugs has been expanding at a significant pace in recent years. With the obvious driving factor being the surge in obesity levels around the globe, this market is also propelled by the strong pipeline of anti-obesity drugs. Advanced medical research by drug-manufacturing companies, medical universities and institutes, and government agencies has also substantially contributed toward the growth of the anti-obesity drugs market. The anti-obesity drugs market in North America has been flourishing over the years owing to the high level of awareness among the population about obesity and the various risks arising from the medical condition, increased healthcare expenditure, the presence of favorable reimbursement policies, extensive research and development activities in the field, and the increased involvement of government as well as non-government organizations in generating awareness and funding research. The Asia Pacific market for anti-obesity drugs is anticipated to gain momentum in the coming years thanks to the rise in obese population, resulting from increased spending on processed and packaged foods and the growing consumption of sugar- sweetened beverages. Improving healthcare infrastructure and mounting healthcare expenditure is also expected to drive the market for anti-obesity drugs in APAC. Global Anti-Obesity Drugs Market: Competitive Landscape Snapshot The leading companies operating in the global anti-obesity drugs market include Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., Takeda Pharmaceuticals Company Limited, Zydus Cadila, Rhythm Pharmaceuticals, Merck & Co. Inc., Eisai Co. Ltd., Novo Nordisk A/S, Orexigen Therapeutics Inc., Zafgen, GlaxoSmithKline PLC, Norgine B.V., Pfizer Inc., and F. Hoffmann- La Roche AG. Owing to the increasing prevalence of obesity in several parts of the world, the degree of competition among players in the anti-obesity drugs market has been on the rise. Companies have been heavily investing in the development of agents with increased weight-loss efficacy and a high safety threshold. This gives players a greater chance of approval from regulatory bodies such as the US FDA. Companies around the globe are also focused on the development as well as successful commercialization of anti-obesity drugs that are both clinically effective and safe in the long run and also have the potential to generate massive sales and reach blockbuster status. The current portfolio of prescription weight-loss drugs and emerging anti-obesity drugs in pre-clinical or clinical trials acts as a significant force driving the global anti-obesity drugs market.

  4. The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12461 The study is a source of reliable data on: Market segments and sub-segments • Market trends and dynamics • Supply and demand • Market size • Current trends/opportunities/challenges • Competitive landscape • Technological breakthroughs • Value chain and stakeholder analysis • The regional analysis covers: North America (U.S. and Canada) • Latin America (Mexico, Brazil, Peru, Chile, and others) • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg) • Eastern Europe (Poland, Russia) •

  5. Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand) • Middle East and Africa (GCC, Southern Africa, North Africa) • The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period. Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market • Important changes in market dynamics • Market segmentation up to the second or third level • Historical, current, and projected size of the market from the standpoint of both value and volume • Reporting and evaluation of recent industry developments • Market shares and strategies of key players • Emerging niche segments and regional markets • An objective assessment of the trajectory of the market • Recommendations to companies for strengthening their foothold in the market •

  6. About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

More Related